Trial intelligence / Profile preview

Changweishu capsule for spleen and stomach damp-heat syndrome in cancer patients

ChiCTR1800016605Phase 4Not yet recruiting

Sponsor
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Start
Jul 2018
Countries
1
01

Overview

Phase 4, open-label trial of Changweishu in Pi Wei dampness heat syndrome (4 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: TCM syndrome. Planned start Jul 2018; status: not yet recruiting.

02

Drugs

Changweishu
03

Conditions

Pi Wei dampness heat syndrome

Beyond the preview

Go deeper on ChiCTR1800016605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800016605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call